Amundi MSCI UK IMI SRI (EPA:FTSE)
France · Delayed Price · Currency is EUR · Price in GBP | Assets | 58.81M |
| Expense Ratio | 0.18% |
| PE Ratio | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +13.66% |
| Volume | 7 |
| Open | 13.63 |
| Previous Close | 13.55 |
| Day's Range | 13.63 - 13.63 |
| 52-Week Low | 10.94 |
| 52-Week High | 13.65 |
| Beta | 1.27 |
| Holdings | 112 |
| Inception Date | Dec 13, 2016 |
About FTSE
Amundi MSCI UK IMI SRI is an exchange traded fund launched by Amundi Luxembourg S.A. It is managed by Amundi Asset Management. The fund invests in the public equity markets of the United Kingdom. It uses derivatives such as swaps to invest in the stocks of companies operating across diversified sectors. The fund invests in the stocks of large-cap companies. It seeks to replicate the performance of the FTSE 100 Index, by employing synthetic replication methodology. Formerly known as Amundi Index Solutions - Amundi ETF FTSE 100. Amundi MSCI UK IMI SRI was formed on June 29, 2016 and is domiciled in Luxembourg.
Performance
FTSE had a total return of 13.66% in the past year, including dividends. Since the fund's inception, the average annual return has been -90.06%.
Top 10 Holdings
46.62% of assets| Name | Symbol | Weight |
|---|---|---|
| AstraZeneca PLC | AZN | 7.71% |
| Barclays PLC | BARC | 5.48% |
| Lloyds Banking Group plc | LLOY | 5.18% |
| GSK plc | GSK | 5.07% |
| Reckitt Benckiser Group plc | RKT | 4.97% |
| 3i Group plc | III | 4.53% |
| RELX PLC | REL | 4.28% |
| National Grid plc | NG | 4.07% |
| Standard Chartered PLC | STAN | 3.01% |
| Ashtead Group plc | AHT | 2.32% |